Facebook Twitter LinkedIn

DorsaVi (ASX:DVL)

DorsaVi (ASX:DVL) has been operating a Sensor business for many years and recently signed a 5-year deal with the largest chain of physical therapy clinics in the United States with >1,900 clinical sites. Additionally, the company is developing very promising ReRAM IP. From an investor point of view, DorsaVi is a high-growth clinical Tech play combined with an emerging semiconductor IP angle.
Contact Us

Research List

PDF Icon 20/05/2026 – DorsaVi hits the road toward 22nm ReRAM
PDF Icon 29/04/2026 – A high-potential semiconductor IP play
PDF Icon 19/12/2025 – Entering the neuromorphic realm
PDF Icon 04/12/2025 – New ReRAM kid on the block

Management Interviews

DorsaVi hits the road toward 22nm ReRAM

DorsaVi hits the road toward 22nm ReRAM

Date: 19/05/2026

We spoke to Mathew Regan, Group CEO of DorsaVi (ASX:DVL), about DVL's announcement that 3 ReRAM material stacks have successfully passed BEOL compatibility testing, which is a very big deal for the company's ambitions in the ReRAM space. We talked about the specifics of the technology and why this matters so much. And we discussed the development roadmap for DorsaVi from here on out, including for neuromorphic processing and In-Memory Compute.

DorsaVi (ASX:DVL) unveiled its ambitious 22nm ReRAM strategy: Interview with Group CEO Mathew Regan

DorsaVi (ASX:DVL) unveiled its ambitious 22nm ReRAM strategy: Interview with Group CEO Mathew Regan

Date: 28/01/2026

We spoke to DorsaVi's Group CEO, Mat Regan, about the company's new research collaboration with ITRI in Taiwan, and how this fits into DVL's 22 nanometer ReRAM development strategy. DorsaVi already has a R&D collaboration in place with NTU in Singapore and has recently acquired an extensive neuromorphic processing IP portfolio. We also spoke about end applications for the technology once commercially available. These include Robotics and Medical applications as well as Autonomous Vehicles, like drones and cars. Lastly, we discussed one of DVL's target markets for neuromorphic computing, which is expected to grow very fast in the next 5 to US$20bn in 2030.

Recent

Latest Research Insights

View All

Related Companies

Register for the Conference